Advanced Supercon, Inc. (ASCI) in Billerica, Massachusetts, a new subsidiary of Bruker Corporation (NASDAQ: BRKR), announced today that it has hired Thomas M. Rosa as Chief Financial Officer and Senior Vice President, and that it is establishing business development and

FDA approved Amitiza for the treatment of Irritable Bowel Syndrome with Constipation in adult women aged 18 and over.

Maximum Life Nutraceuticals Inc. made an application with the Saudi Ministry of Health to have its contract manufacturer registered as a Saudi approved GMP facility recently recieved approval on April 22,2008. Maximum Life, in order to register its products in

PepCenter© streamlines production, communication with centralized data management. (PRWeb Apr 30, 2008) Read the full story at http://ww1.prweb.com/releases/2008/04/prweb898984.htm

ICD Global, a print and fulfillment house specialized in clinical trial documents, announces the availability of warehousing and worldwide distribution for patient recruitment literature and marketing kits. (PRWeb Apr 30, 2008) Read the full story at http://ww1.prweb.com/releases/2008/04/prweb897914.htm

M2S Inc., an industry leader in medical image management and analysis, has released new auto blinding technology for the DICOM Armorcar® (DAC®). M2S's DAC image transfer technology has revolutionized the way medical images are transported between sites, core labs and

LegalView recently updated its Heparin information portal on the latest news regarding the contaminated batch of Heparin, which may have sickened hundreds and caused the death of up to 90 individuals. U.S. officials have sourced the contamination to a manufacturing

Boehringer Ingelheim enjoyed continued success through 2007, its growth outpacing the pharmaceuticals market for the eighth time in succession. As the Company announced at its annual press conference in Ingelheim, turnover rose by +8.8% in local currency (+3.6% in euro

The results of the landmark ONTARGET Trial have proven that telmisartan, brand name MICARDIS, a modern Angiotensin II Receptor Blocker (ARB), is as protective as the current gold standard, ramipril, in reducing the risk of cardiovascular death, myocardial infarction, stroke,

Dynavax Technologies Corporation (Nasdaq: DVAX) today reported financial results for the first quarter ended March 31, 2008. (PRWeb Apr 29, 2008) Read the full story at

The fact that the heart failure treatment drug Digitek (Digoxin) may contain twice the approved level of active ingredient than is appropriate has prompted Digitek recall by Actavis Totowa.